Oxybenzone

For Photoprotection (Sunscreen)

• Standard Application: Apply a liberal amount (approximately 2mg/cm² of skin) to all exposed areas 15 to 30 minutes before sun exposure.
• Reapplication: Healthcare providers typically recommend reapplying every two hours, or more frequently after swimming, sweating, or towel drying.

For Diagnostic Patch Testing

• Dosage: Typically administered as a 3% concentration in petrolatum, applied to the back under occlusion for 48 hours as part of a standard allergen series.

• Infants under 6 months: The American Academy of Pediatrics (AAP) generally advises against the use of chemical sunscreens like oxybenzone in infants under 6 months unless directed by a physician. Physical blockers (Zinc Oxide/Titanium Dioxide) are often preferred.
• Children over 6 months: Use as directed for adults, ensuring thorough coverage and frequent reapplication.

Renal Impairment

No specific dosage adjustments are currently required for topical application, though systemic absorption should be considered in patients with end-stage renal disease.

Hepatic Impairment

Since oxybenzone is metabolized by the liver, patients with severe hepatic dysfunction should consult a doctor before frequent, whole-body application.

Elderly Patients

No specific adjustments are required; however, elderly patients may have thinner skin, which could potentially increase systemic absorption.

Oxybenzone is for external use only. It should never be ingested. Avoid contact with eyes, nostrils, and mouth. If the product is an aerosol spray, do not inhale the vapor and avoid spraying directly onto the face; instead, spray into hands and then apply to the face.

If you forget to apply oxybenzone before sun exposure, apply it as soon as you remember. Note that the protective effect is not retroactive; skin damage may have already occurred during the unprotected interval.

Topical overdose is rare but may manifest as severe skin irritation or a systemic allergic reaction. If accidental ingestion occurs, contact a Poison Control Center immediately. Symptoms of ingestion may include gastrointestinal distress or CNS depression.

> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose or application frequency without medical guidance.

• Mild Skin Irritation: A transient stinging or burning sensation immediately after application.
• Erythema: Temporary redness of the treated area.

• Contact Dermatitis: Itchy, red, or scaly skin at the site of application.
• Acneiform Eruptions: Clogging of pores leading to small bumps or breakouts, particularly in oil-rich areas.

• Photoallergic Reaction: A skin rash that only appears after the skin, treated with oxybenzone, is exposed to sunlight.
• Urticaria: Hives or welts appearing on the skin.

> Warning: Stop using Oxybenzone and call your doctor immediately if you experience any of these:

• Anaphylaxis: Difficulty breathing, swelling of the face, lips, or tongue, and severe dizziness.
• Severe Blistering: Extensive skin peeling or painful blisters at the application site.
• Systemic Allergic Response: Generalized rash accompanied by fever or joint pain.

There is ongoing clinical debate regarding the long-term effects of systemic oxybenzone absorption. Some studies in animal models have suggested potential endocrine-disrupting effects (interference with hormones), though human clinical significance remains a subject of active research by the FDA and the European SCCS (Scientific Committee on Consumer Safety).

No FDA black box warnings are currently issued for Oxybenzone. It remains an FDA-approved OTC ingredient for sun protection.

Report any unusual symptoms or persistent skin changes to your healthcare provider.

Oxybenzone is generally safe for topical use, but patients should be aware of its potential for systemic absorption and environmental impact. It is one of the most common causes of photoallergic contact dermatitis among sunscreen ingredients.

No FDA black box warnings for Oxybenzone.

• Allergic Reactions: Patients with a known sensitivity to benzophenones should avoid oxybenzone. A patch test is recommended for individuals with sensitive skin or a history of cosmetic allergies.
• Skin Penetration: Because oxybenzone penetrates the stratum corneum (the outermost layer of skin), it should not be applied to open wounds, severely damaged skin, or large areas of broken skin.
• Environmental Warning: Certain jurisdictions (e.g., Hawaii, U.S. Virgin Islands) have restricted the sale of oxybenzone-containing sunscreens due to evidence suggesting it contributes to coral reef bleaching and marine toxicity.

Routine lab tests are not typically required for standard topical use. However, if used as part of a diagnostic allergy workup, follow-up skin assessments at 48 and 72 hours are mandatory.

Topical oxybenzone does not typically affect the ability to drive or operate machinery.

There are no known direct interactions between topical oxybenzone and alcohol consumption.

If a rash or irritation develops, discontinue use immediately. No tapering is required for this topical agent.

> Important: Discuss all your medical conditions, especially history of skin cancer or chronic dermatitis, with your healthcare provider before starting Oxybenzone.

There are no known systemic medications that are absolutely contraindicated with the topical use of oxybenzone. However, it should not be used simultaneously with other topical agents that may increase skin permeability unless directed by a physician.

• Topical Retinoids (e.g., Tretinoin): Using oxybenzone on skin already irritated by retinoids may increase the risk of severe contact dermatitis. Monitor for excessive peeling and redness.

• Insect Repellents (DEET): Studies have shown that oxybenzone can enhance the systemic absorption of DEET when applied together. This may increase the risk of DEET-related toxicity. If used together, apply the sunscreen first and the repellent second, or use a lower concentration of DEET.

No significant interactions with food, dairy, or caffeine have been identified for topical oxybenzone.

There are no documented interactions between topical oxybenzone and common herbal supplements like St. John's Wort or Ginkgo Biloba.

Oxybenzone metabolites in the urine may potentially interfere with certain spectrophotometric assays. If you are undergoing a 24-hour urine collection for metabolic studies, inform your doctor if you are using high concentrations of sunscreen.

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including any other topical treatments.

• Hypersensitivity: Oxybenzone must NEVER be used in individuals with a documented allergy to benzophenone-3 or any other benzophenone derivatives. Exposure can lead to severe allergic contact dermatitis or anaphylaxis.
• Infants under 6 months: Due to the higher surface-area-to-mass ratio and immature skin barrier, oxybenzone is generally contraindicated in this age group unless specifically advised by a pediatrician.

• Eczema/Atopic Dermatitis: Patients with compromised skin barriers may experience increased irritation and higher systemic absorption.
• Photosensitivity Disorders: While oxybenzone protects against UV, some patients with specific photodermatoses may react to the chemical filter itself.

Patients allergic to oxybenzone may also react to related compounds, including:

• Dioxybenzone
• Sulisobenzone
• Octocrylene (in rare cases of cross-reactivity)

> Important: Your healthcare provider will evaluate your complete medical history and any history of skin reactions before prescribing or recommending Oxybenzone.

FDA Pregnancy Category: Not Formally Assigned.

Oxybenzone is known to be absorbed systemically. Some epidemiological studies have investigated links between oxybenzone exposure and birth weight or gestational age, but results have been inconsistent. The American College of Obstetricians and Gynecologists (ACOG) has not issued a formal ban, but many providers suggest pregnant patients consider mineral-based sunscreens (Zinc Oxide) as a precautionary measure.

Oxybenzone has been detected in human breast milk. While the clinical impact on the nursing infant is unknown, the potential for systemic absorption suggests that nursing mothers should avoid applying oxybenzone-containing products directly to the nipple area to prevent accidental ingestion by the infant.

Oxybenzone is approved for use in children over 6 months of age. However, children are at a higher risk for skin irritation. Healthcare providers often recommend "tear-free" or mineral formulations for pediatric patients to avoid eye irritation.

No specific age-related changes in efficacy have been noted. However, elderly patients should be monitored for skin thinning and increased susceptibility to contact dermatitis.

While systemic absorption occurs, the amount is typically small enough that standard topical use is not restricted in renal impairment. However, chronic, whole-body use should be discussed with a nephrologist.

As the liver is the primary site of metabolism for absorbed oxybenzone, patients with significant liver disease should use these products judiciously.

> Important: Special populations require individualized medical assessment to weigh the benefits of UV protection against potential systemic risks.

Oxybenzone acts as a broad-spectrum UV filter. Its chemical structure, featuring a conjugated pi-system, allows it to absorb UV photons (primarily in the 270–350 nm range). This absorption promotes an electron to a higher energy state; the molecule then undergoes internal conversion to dissipate this energy as heat. As a Melanin Synthesis Inhibitor, it may inhibit the activity of tyrosinase, though the clinical relevance of this in human skin pigmentation is less documented than its photoprotective role.

The onset of photoprotection is immediate upon application, though 15–30 minutes is required for the formulation to form a uniform film on the skin. The duration of effect is typically 2 hours, after which mechanical loss (rubbing) and degradation necessitate reapplication.

| Parameter | Value |

|---|---|

| Bioavailability | Systemically absorbed (approx. 1-10% of applied dose) |

| Protein Binding | High (Albumin) |

| Half-life | 4 - 15 hours |

| Tmax | 2 - 8 hours (plasma) |

| Metabolism | Hepatic (Glucuronidation/Sulfation) |

| Excretion | Renal (90% as metabolites) |

• Molecular Formula: C14H12O3
• Molecular Weight: 228.24 g/mol
• Solubility: Insoluble in water; soluble in alcohol and organic solvents.
• Structure: A benzophenone derivative with a hydroxyl group and a methoxy group.

Oxybenzone is a member of the benzophenone class of organic compounds. Related medications include dioxybenzone and sulisobenzone. It is distinct from physical blockers like Zinc Oxide, which reflect rather than absorb UV light.